Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
18899-5 Cephaloridine Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Cephaloridine [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18899-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Cephaloridine Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Loridine; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
189-1 Clarithromycin Susc Isolate Pt OrdQn MIC &nbsp; ACTIVE Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 189-1 &nbsp; MIC &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Clarithro Islt MIC &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Biaxin; Claripen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klacid; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
1890-3 Arginase CCnc RBC Pt Qn &nbsp; &nbsp; ACTIVE Arginase [Enzymatic activity/volume] in Red Blood Cells &nbsp; MIN DefinitionDescription &nbsp; &nbsp; U/mL RBC &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 1890-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Arginase RBC-cCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Catalytic Concentration; Chemistry; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; U/mL{RBCs} &nbsp; &nbsp; &nbsp; 0
18900-1 Cephalothin Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Cephalothin [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18900-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Cephalothin Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefalotin; Cephalotin; Ceporacin; Cepovenin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Keflin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.73 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18901-9 Cephapirin Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Cephapirin [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18901-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Cephapirin Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefadyl; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18902-7 Cephradine Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Cephradine [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18902-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Cephradine Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Anspor; ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefamid; Cefrabiotic; Cefradine; Cefral; Cefrasol; Cefril; Celex; Cesporan; Citicef; Ecosporina; Eskacef; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kelsef; Lenzacef; Lisacef; Maxisporin; Point in time; Random; Samedrin; Sefril; Septacef; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Velocef; Velosef 2.19 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18903-5 Chloramphenicol Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Chloramphenicol [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18903-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Chloramphen Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Amphicol; ANTIBIOTIC SUSCEPTIBILITIES; AST; Biophenicol; c225; Chloramphen; Chloromycetin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Mychel; Paraxin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.73 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18904-3 Chlortetracycline Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Chlortetracycline [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18904-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Chlortetracycline Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Aureomycin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18905-0 Cinoxacin Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Cinoxacin [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18905-0 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Cinoxacin Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Azolinic acid; Cinobac; Cinobactin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Nofrin; Nossacin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Uronorm; Uroxacin 2.73 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18906-8 Ciprofloxacin Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Ciprofloxacin [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18906-8 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Ciprofloxacin Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.73 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18907-6 Clarithromycin Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Clarithromycin [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18907-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Clarithro Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Biaxin; Claripen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klacid; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.73 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18908-4 Clindamycin Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Clindamycin [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18908-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Clindamycin Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; c306; Cleocin; CLIJ; Dalacin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sobelin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Topical 2.73 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18909-2 Clotrimazole Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Clotrimazole [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18909-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Clotrimazole Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
1891-1 Arginine MCnc CSF Pt Qn &nbsp; &nbsp; DISCOURAGED Arginine [Mass/volume] in Cerebral spinal fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 1891-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Arginine CSF-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Arg; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.44 1 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
18910-0 Cloxacillin Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Cloxacillin [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18910-0 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Cloxacillin Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Alclox; Ampiclox; Amplium; ANTIBIOTIC SUSCEPTIBILITIES; APO-CLOXI; AST; Austrastaph; Clocillin; Cloxin; Ekvacillin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Novo-cloxi; Nu-cloxi; Orbenin; Penstapho n; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tegopen 2.19 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18911-8 Colistimethate Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Colistimethate &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18911-8 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Colistimethate Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Colimicina; Colimycine; Colistin sulphomethate; Colomycin M; Coly-micin S; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18912-6 Colistin Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Colistin [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18912-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Colistin Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Colmycin; Colymycin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.73 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18913-4 Cyclacillin Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Cyclacillin [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18913-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Cyclacillin Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Calthor; Ciclacillin; Cyclapen-w; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Wypicil 2.19 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18914-2 cycloSERINE Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE cycloSERINE [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18914-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 cycloSERINE Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Closina; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Oxamycin; Point in time; Random; Seromycine; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18915-9 Demeclocycline Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Demeclocycline [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18915-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Demeclocycline Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Clortetrin; Declomycin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Iticiclina; Ledermycin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18916-7 Dicloxacillin Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Dicloxacillin [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18916-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Dicloxacillin Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Dynapen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Pathocil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Veracillin; Veracilline 2.73 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18917-5 Doxycycline Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Doxycycline [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18917-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Doxycycline Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; c206; c216; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vibramycin 2.73 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18918-3 Enoxacin Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Enoxacin [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18918-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Enoxacin Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Almitil; ANTIBIOTIC SUSCEPTIBILITIES; AST; Bactidan; Comprecin; Enoxen; Flumark; Gyramid; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Penetrex; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.73 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
18919-1 Erythromycin Susc Isolate Pt OrdQn &nbsp; &nbsp; ACTIVE Erythromycin [Susceptibility] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 18919-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Erythromycin Susc Islt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; c212; EES; Erygel; Erythromycn; ID; Ilosone; Ilotycin; Iltycin; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.73 1.0l &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
1892-9 Arginine PrThr Ser/Plas Pt Ord &nbsp; &nbsp; ACTIVE Arginine [Presence] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 1892-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Arginine SerPl Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Arg; Chemistry; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
104,672 results found